Ybañez, Conchita N.

HRN: 22-17-30  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/05/2022
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
11/05/2022
11/11/2022
IV
1.5G
Q6
Wound Infection
Waiting Final Action 
11/05/2022
CLINDAMYCIN 150MG/ML, 4ML (AMP)
11/05/2022
11/11/2022
IV
600 Mg
Q6H
Wound Infection
Waiting Final Action 
11/05/2022
MUPIROCIN 2%, 15G (TUBE)
11/05/2022
11/11/2022
TOPICAL
2%
BID
Wound Infection
Waiting Final Action 
11/06/2022
CO-AMOXICLAV 625MG (TAB)
11/06/2022
11/12/2022
PO
625 Mg
BiD
Wound Infection
Waiting Final Action 
11/06/2022
CLINDAMYCIN 300MG (CAP)
11/06/2022
11/12/2022
PO
300 Mg
Q6
Wound Infection
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: